FDA draws up guidelines for MRA (mutual recognition agreement) with Europe
This article was originally published in Clinica
Executive Summary
The FDA has published a guidance on how private third parties will be chosen to serve as conformity assessment bodies (CABs) under the mutual recognition agreement between the US and European Union covering medical devices.